Novo Nordisk A/S Common Stock (NVO) R&D to Revenue & History | Stock Alarm

Demo Sign up Log In

Novo Nordisk A/S Common Stock · R&D to Revenue

NVO R&D to Revenue

Latest reported16.84%period endingDec 31, 2025

NVO FY R&D/Revenue (0.00% → 16.84%)

Latest values, visible window

High-resolution chart · PNG

NVO r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock R&D to Revenue — Annual fiscal periods
Period ending	R&D to Revenue
Dec 31, 2025	16.8376%
Dec 31, 2024	16.5501%
Dec 31, 2023	13.9683%
Dec 31, 2022	13.5894%
Dec 31, 2021	12.6222%
Dec 31, 2020	12.18%
Dec 31, 2019	11.6537%
Dec 31, 2018	13.2387%
Dec 31, 2017	12.5466%
Dec 31, 2016	13.0283%
Dec 31, 2015	12.6085%
Dec 31, 2014	15.4967%
Dec 31, 2013	14.0394%
Dec 31, 2012	13.9659%
Dec 31, 2011	14.5118%
Dec 31, 2010	15.799%
Dec 31, 2009	15.3961%
Dec 31, 2008	17.2426%
Dec 31, 2007	20.4126%
Dec 31, 2006	16.3021%
Dec 31, 2005	15.0524%
Dec 31, 2004	14.9991%
Dec 31, 2003	15.7965%
Dec 31, 2002	16.4322%
Dec 31, 2001	16.696%
Dec 31, 2000	15.4913%
Dec 31, 1999	16.0254%
Dec 31, 1998	18.9758%
Dec 31, 1997	16.3072%
Dec 31, 1996	0%
Dec 31, 1995	0%
Dec 31, 1994	0%
Dec 31, 1993	0%
Dec 31, 1992	0%
Dec 31, 1991	0%
Dec 31, 1990	0%
Dec 31, 1989	0%
Dec 31, 1988	0%
Dec 31, 1987	0%
Dec 31, 1986	0%
Dec 31, 1985	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.